WallStreetZenWallStreetZen
Analyst Ranking
Top 11%
#462 out of 4587 analysts
Average Return
+13.88%
Win Rate
57%39 out of 69
Risk vs Reward
Poor
Good

Jessica Fye's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Rayzebio IncRYZB
+212.45%$20.00$62.49
2023-10-09 -
2024-02-23
Strong Buy
Stemline Therapeutics IncSTML
+178.35%$4.25$11.83
2020-03-25 -
2020-06-10
Strong Buy
Ascendis Pharma AASND
+134.77%$27.90$65.50
2017-05-10 -
2018-05-11
Strong Buy
Tricida IncTCDAQ
+80.43%$0.55$0.11
2022-10-24 -
2023-01-23
Strong Sell
Nektar TherapeuticsNKTR
+79.06%$4.87$1.02
2022-08-07 -
2023-08-07
Strong Sell

Jessica Fye's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ascendis Pharma AASND
3Strong Buy$170.00+40.36%Maintains
15 days ago
Stoke Therapeutics IncSTOK
2Hold$13.00-6.47%Maintains
2 months ago
Biontech SeBNTX
5Strong Sell$90.00-0.67%Maintains
2 months ago
Jazz Pharmaceuticals PLCJAZZ
2Strong Buy$190.00+74.33%Maintains
2 months ago
Deciphera Pharmaceuticals IncDCPH
4Hold$16.00-37.16%Maintains
2 months ago
Immunocore Holdings PLCIMCR
3Strong Buy$70.00+31.36%Maintains
2 months ago
Beigene LtdBGNE
2Strong Buy$186.00+7.61%Maintains
2 months ago
Novocure LtdNVCR
3Hold$17.00-22.69%Maintains
2 months ago
Vertex Pharmaceuticals IncVRTX
4Strong Buy$450.00+1.08%Maintains
3 months ago
Ionis Pharmaceuticals IncIONS
1Hold$55.00+47.41%Maintains
4 months ago
Cerevel Therapeutics Holdings IncCERE
4Hold$45.00+6.89%Maintains
5 months ago
Karuna Therapeutics IncKRTX
1Hold$330.00+0.05%Downgrades
5 months ago
Moderna IncMRNA
5Hold$90.00-32.28%Maintains
6 months ago
Biocryst Pharmaceuticals IncBCRX
2Strong Buy$10.00+59.24%Reinstates
6 months ago
Mirum Pharmaceuticals IncMIRM
2Strong Buy$37.00+53.72%Reinstates
6 months ago
Crinetics Pharmaceuticals IncCRNX
2Strong Buy$35.00-31.91%Reinstates
6 months ago
Denali Therapeutics IncDNLI
2Strong Buy$28.00+36.52%Reinstates
6 months ago
Insmed IncINSM
2Strong Buy$36.00+45.34%Reinstates
6 months ago
Alkermes PLCALKS
3Hold$33.00+36.65%Reinstates
6 months ago
Rayzebio IncRYZB
1Strong Buy$30.00-51.99%Initiates Coverage On
7 months ago
Intra Cellular Therapies IncITCI
3Strong Buy$62.00-4.62%Maintains
a year ago
Legend Biotech CorpLEGN
2Strong Buy$76.00N/AMaintains
a year ago
Emergent Biosolutions IncEBS
1Strong Sell$9.00N/ADowngrades
a year ago
Esperion Therapeutics IncESPR
5Hold$9.00N/AMaintains
a year ago
Halozyme Therapeutics IncHALO
3Strong Buy$52.00N/AMaintains
a year ago
Seagen IncSGEN
2Strong Buy$150.00N/AMaintains
a year ago
Incyte CorpINCY
2Hold$80.00N/AMaintains
a year ago
United Therapeutics CorpUTHR
5Strong Buy$265.00N/AMaintains
2 years ago
Tricida IncTCDAQ
2Strong SellN/AN/ADowngrades
2 years ago
Biomarin Pharmaceutical IncBMRN
1Strong Buy$112.00N/AMaintains
2 years ago
Alnylam Pharmaceuticals IncALNY
1Hold$200.00N/AMaintains
2 years ago
Nektar TherapeuticsNKTR
2Strong SellN/AN/ADowngrades
2 years ago
Amarin Corp PLCAMRN
1Strong SellN/AN/ADowngrades
2 years ago
Cara Therapeutics IncCARA
2Strong Buy$20.00N/AUpgrades
2 years ago
Landos Biopharma IncLABP
2Hold$70.00N/AMaintains
2 years ago
Dianthus Therapeutics IncDNTH
1Hold$7.00N/ADowngrades
3 years ago
Lava Therapeutics NvLVTX
1Strong Buy$22.00N/AInitiates Coverage On
3 years ago
Aptinyx IncAPTX
1Strong SellN/AN/ADowngrades
3 years ago
Lexicon Pharmaceuticals IncLXRX
1Hold$7.00N/AUpgrades
3 years ago
Stemline Therapeutics IncSTML
2Strong Buy$8.00N/AMaintains
4 years ago
Arena Pharmaceuticals IncARNA
1Strong Buy$58.00N/AUpgrades
4 years ago
Axcella Health IncAXLA
2Strong Buy$275.00N/AMaintains
5 years ago
Aprea Therapeutics IncAPRE
1Hold$460.00N/AInitiates Coverage On
5 years ago
Mersana Therapeutics IncMRSN
4Strong SellN/AN/ADowngrades
5 years ago
Amag Pharmaceuticals IncAMAG
1Strong Sell$18.00N/ADowngrades
6 years ago
Radius Health IncRDUS1
4Strong Buy$52.00N/AMaintains
6 years ago
Chimerix IncCMRX
1Strong SellN/AN/ADowngrades
6 years ago
Enanta Pharmaceuticals IncENTA
1HoldN/AN/ADowngrades
6 years ago
Advanced Accelerator Applications SaAAAP
1HoldN/AN/ADowngrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.